Organization
Biotech Pharmaceutical
10 clinical trials
Clinical trial
Randomized Double-blind, Placebo-controlled, Multicenter Clinical Study of Nimotuzumab Combined With Trifluridine/Tipiracil in Third-line and Beyond for the Treatment of Metastatic Colorectal CancerStatus: Not yet recruiting, Estimated PCD: 2027-04-01
Clinical trial
A Prospective, Randomized, Controlled, Double-blind, Multi-center Clinical Study of Nimotuzumab Combinated With Gemcitabine Contrast to Placebo Combinated With Gemcitabine in K-RAS Wild-type,Locally Advanced and Metastatic Pancreatic CancerStatus: Completed, Estimated PCD: 2021-11-01
Clinical trial
Nimotuzumab Combined With Paclitaxel as Second-line Treatment for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma With EGFR Over-expression: A Randomized, Double-blind, Placebo-controlled Phase III Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2026-03-01
Clinical trial
A Phase 1 Study to Evaluate the Safety, Tolerability and Preliminary Clinical Activity of Itolizumab in Subjects With Acute Respiratory Distress Syndrome Caused by Infectious PneumoniaStatus: Not yet recruiting, Estimated PCD: 2025-11-30
Clinical trial
A Multicentre, Prospective, Randomized, Double-blind, Placebo-controlled Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Locally Advanced Cervical Squamous Cell CarcinomaStatus: Not yet recruiting, Estimated PCD: 2030-04-01
Clinical trial
A Real-world Study of the Efficacy and Safety of Nimotuzumab in Combination With Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell CarcinomaStatus: Completed, Estimated PCD: 2023-03-15
Clinical trial
A Phase 1 Study to Evaluate the Safety, Tolerability and Preliminary Clinical Activity of Itolizumab in Subjects With DermatomyositisStatus: Not yet recruiting, Estimated PCD: 2025-05-03
Clinical trial
A Multicenter, Prospective, Open and Single Arm Clinical Study of Nimotuzumab Combined With Concurrent Radiochemotherapy in the Treatment of Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in ChildrenStatus: Recruiting, Estimated PCD: 2023-10-08
Clinical trial
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Itolizumab in Subjects With Newly Diagnosed Acute Graft Versus Host DiseaseStatus: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
Single and Multiple Dose -Based Tolerability, Safety and Pharmacokinetic Phase 1 Study of Humanized Anti-CD6 Monoclonal Antibody Injection in Chinese Patients With PsoriasisStatus: Terminated, Estimated PCD: 2015-06-01